Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Progression

Tumor Progression

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors.

Immunity·2026

Same author

Deep neural networks and genome-wide associations reveal the polygenic architecture of local brain aging.

GeroScience·2025

Same author

Structural changes from wild-type define tumor-rejecting neoantigens.

Journal for immunotherapy of cancer·2025

Same author

A Comparison of the Tibial Intraosseous Route With the Peripheral Intravenous Route for Fluid Resuscitation of Patients in Hypovolemic Shock.

Cureus·2025

Same author

Reproducible autosomal gene expression changes with loss of typical X and Y complement across tumor types.

bioRxiv : the preprint server for biology·2025

Same author

Towards a transcriptomic biomarker for the classification of melanocytic neoplasms.

PLoS genetics·2025

Search research articles

Related Experiment Video

Updated: Mar 17, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Tracking Cancer Genetic Evolution using OncoTrack.

Asoke K Talukder¹, Mahima Agarwal¹, Kenneth H Buetow²

¹InterpretOmics, Bangalore, India.

Scientific Reports

|July 15, 2016

Summary

This summary is machine-generated.

Cancer evolution is hard to track due to mutation heterogeneity. SPKMG, a new metric, quantifies DNA changes from NGS reads, enabling efficient tracking of cancer progression and discovery of core cancer genes.

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Experiment Videos

Last Updated: Mar 17, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Area of Science:

Genomics
Cancer Biology
Bioinformatics

Background:

Cancer evolution is complex and difficult to track due to high mutation heterogeneity.
Structural variations in nucleotide numbers present repeatable genomic patterns.
Existing methods struggle to quantify and monitor cancer's dynamic changes.

Purpose of the Study:

Introduce SPKMG, a novel statistical method to generalize nucleotide number-based gene properties genome-wide.
Utilize SPKMG for quantitative analysis of DNA-level changes in cancer.
Enable efficient tracking of tumor progression and evolution using exome data.

Main Methods:

SPKMG is calculated from normalized aligned Next-Generation Sequencing (NGS) reads in exonic regions.
SPKMG values are continuous numeric variables, providing a statistical metric for DNA changes.
The method is implemented within the OncoTrack framework.

Main Results:

SPKMG measures reveal a normative pattern in cancer DNA at the genome-wide scale.
The analysis identified core cancer genes.
Novel dynamic insights into cancer development, progression, and metastasis were obtained.

Conclusions:

SPKMG offers a powerful statistical metric for tracking DNA-level changes in cancer.
This technique enhances the utility of exome data for quantitative LOH/CNV analysis.
SPKMG facilitates more efficient monitoring of tumor progression and evolution.